IVF 기기 및 소모품 시장 : 제품별, 기술별, 최종사용자별, 지역별(2025-2033년)

The global IVF devices and consumables market size reached USD 3.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.9 Billion by 2033, exhibiting a growth rate (CAGR) of 12.11% during 2025-2033.

In vitro fertilization (IVF) is an assisted reproductive technology (ART) that helps with fertility, prevents genetic problems, and assists in the conception of a child. It comprises several medicines and surgical procedures for ovulation, egg retrieval, insemination and fertilization, and embryo culture and transfer. It also helps in achieving a successful pregnancy and healthy baby in women with blocked or damaged fallopian tubes. In addition, it aids in male infertility problems by using intra-cytoplasmic sperm injection (ICSI) for conceiving. At present, there is a rise in the utilization of IVF devices and consumables, such as instruments, accessories and disposable, and reagents and media, on account of the increasing rate of infertility across the globe.

IVF Devices and Consumables Market Trends:

The rising awareness among the masses about the benefits of using IVF devices and consumables for a successful pregnancy represents one of the key factors propelling the market growth. Besides this, there is an increase in the number of delayed pregnancies worldwide. This, along with the burgeoning healthcare industry, is contributing to the growth of the market. Moreover, the rising number of gamete donations around the world to help intended parents have a child is offering lucrative growth opportunities to industry investors. In addition, governments of several countries are extensively investing in healthcare infrastructures, which is positively influencing the market. Apart from this, key market players are financing research and development (R&D) activities for improving embryo culture and cryopreservation and in vitro maturation. They are also focusing on several marketing strategies to increase their customer base. Additionally, the integration of artificial intelligence (AI) in IVF for the identification of an embryo is bolstering the growth of the market.

Key Market Segmentation:

Breakup by Product:

• Instruments
• Sperm Separation Systems
• Cryosystems
• Incubators
• Imaging Systems
• Ovum Aspiration Pumps
• Cabinets
• Micromanipulators
• Others
• Accessories and Disposables
• Reagents and Media
• Cryopreservation Media
• Semen Processing Media
• Ovum Processing Media
• Embryo Culture Media

Breakup by Technology:

• Fresh Embryo IVF
• Frozen Embryo IVF
• Donor Egg IVF

Breakup by End User:

• Fertility Clinics
• Hospitals
• Surgical Centers
• Clinical Research Institutes

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Coopersurgical Inc. (The Cooper Companies Inc), Esco Medical, FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation), Genea Biomedx, Hamilton Thorne Ltd., INVO Bioscience, Memmert GmbH + Co.KG, Merck KGaA, Nidacon International AB, Rocket Medical Plc, Thermo Fisher Scientific and Vitrolife.

Key Questions Answered in This Report

• 1.What was the size of the global IVF devices and consumables market in 2024?
• 2.What is the expected growth rate of the global IVF devices and consumables market during 2025-2033?
• 3.What are the key factors driving the global IVF devices and consumables market?
• 4.What has been the impact of COVID-19 on the global IVF devices and consumables market?
• 5.What is the breakup of the global IVF devices and consumables market based on the product?
• 6.What is the breakup of the global IVF devices and consumables market based on the technology?
• 7.What is the breakup of the global IVF devices and consumables market based on the end user?
• 8.What are the key regions in the global IVF devices and consumables market?
• 9.Who are the key players/companies in the global IVF devices and consumables market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global IVF Devices and Consumables Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Instruments
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Sperm Separation Systems
    • 6.1.2.2 Cryosystems
    • 6.1.2.3 Incubators
    • 6.1.2.4 Imaging Systems
    • 6.1.2.5 Ovum Aspiration Pumps
    • 6.1.2.6 Cabinets
    • 6.1.2.7 Micromanipulators
    • 6.1.2.8 Others
  • 6.1.3 Market Forecast
• 6.2 Accessories and Disposables
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Reagents and Media
  • 6.3.1 Market Trends
  • 6.3.2 Key Segments
    • 6.3.2.1 Cryopreservation Media
    • 6.3.2.2 Semen Processing Media
    • 6.3.2.3 Ovum Processing Media
    • 6.3.2.4 Embryo Culture Media
  • 6.3.3 Market Forecast

7 Market Breakup by Technology

• 7.1 Fresh Embryo IVF
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Frozen Embryo IVF
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Donor Egg IVF
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End User

• 8.1 Fertility Clinics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Hospitals
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Surgical Centers
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Clinical Research Institutes
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Coopersurgical Inc. (The Cooper Companies Inc)
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Esco Medical
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation)
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Genea Biomedx
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Hamilton Thorne Ltd.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
  • 14.3.6 INVO Bioscience
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
  • 14.3.7 Memmert GmbH + Co.KG
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Merck KGaA
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Nidacon International AB
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Rocket Medical Plc
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Thermo Fisher Scientific
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis
  • 14.3.12 Vitrolife
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio